Turn Therapeutics (TTRX) Cash from Investing Activities (2024 - 2026)
Turn Therapeutics' quarterly Cash from Investing Activities came in at -$12227.0 in Q1 2026, up 61.11% quarter-over-quarter from -$31441.0 in Q4 2025.
Turn Therapeutics has reported Cash from Investing Activities for 3 years, with the latest figure at -$12227.0 in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.89 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 638.50 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -431.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -428.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -25.54 Mn |
| 10 | Turn Therapeutics | 188.06 Mn | 188.06 Mn | - | -12,227.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12,227.00 |
| Mar 31, 2026 | -12,227.00 |
| Dec 31, 2025 | -31,441.00 |
| Dec 31, 2025 | -31,441.00 |
| Dec 31, 2024 | -7,842.00 |
| Dec 31, 2024 | -7,842.00 |